A Pilot Study of Imatinib Mesylate in Children and Adults With Sclerotic Skin Changes of Chronic Graft-Versus-Host Disease.
Phase of Trial: Phase II
Latest Information Update: 21 Dec 2017
At a glance
- Drugs Imatinib (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 01 Jul 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 May 2012 Planned end date changed from 1 Mar 2012 to 1 Jul 2013 as reported by ClinicalTrials.gov.
- 05 Jan 2012 Actual patient number changed from 8 to 20 as reported by ClinicalTrials.gov.